131 related articles for article (PubMed ID: 24792401)
1. Estimating the costs of cervical cancer screening in high-burden Sub-Saharan African countries.
Mvundura M; Tsu V
Int J Gynaecol Obstet; 2014 Aug; 126(2):151-5. PubMed ID: 24792401
[TBL] [Abstract][Full Text] [Related]
2. Costs of cervical cancer screening and treatment using visual inspection with acetic acid (VIA) and cryotherapy in Ghana: the importance of scale.
Quentin W; Adu-Sarkodie Y; Terris-Prestholt F; Legood R; Opoku BK; Mayaud P
Trop Med Int Health; 2011 Mar; 16(3):379-89. PubMed ID: 21214692
[TBL] [Abstract][Full Text] [Related]
3. Trials and projects on cervical cancer and human papillomavirus prevention in sub-Saharan Africa.
Adefuye PO; Broutet NJ; de Sanjosé S; Denny LA
Vaccine; 2013 Dec; 31 Suppl 5():F53-9. PubMed ID: 24331748
[TBL] [Abstract][Full Text] [Related]
4. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.
Kim JJ; Campos NG; O'Shea M; Diaz M; Mutyaba I
Vaccine; 2013 Dec; 31 Suppl 5():F60-72. PubMed ID: 24331749
[TBL] [Abstract][Full Text] [Related]
5. Cervical cancer screening uptake and challenges in Malawi from 2011 to 2015: retrospective cohort study.
Msyamboza KP; Phiri T; Sichali W; Kwenda W; Kachale F
BMC Public Health; 2016 Aug; 16(1):806. PubMed ID: 27535359
[TBL] [Abstract][Full Text] [Related]
6. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.
Sankaranarayanan R; Anorlu R; Sangwa-Lugoma G; Denny LA
Vaccine; 2013 Dec; 31 Suppl 5():F47-52. PubMed ID: 24331747
[TBL] [Abstract][Full Text] [Related]
7. Cost of HPV screening at community health campaigns (CHCs) and health clinics in rural Kenya.
Shen J; Olwanda E; Kahn JG; Huchko MJ
BMC Health Serv Res; 2018 May; 18(1):378. PubMed ID: 29801496
[TBL] [Abstract][Full Text] [Related]
8. Is screen-and-treat approach suited for screening and management of precancerous cervical lesions in Sub-Saharan Africa?
Fokom-Domgue J; Vassilakos P; Petignat P
Prev Med; 2014 Aug; 65():138-40. PubMed ID: 24879892
[TBL] [Abstract][Full Text] [Related]
9. Cost-Effectiveness of Screening and Treatment for Cervical Cancer in Tanzania: Implications for other Sub-Saharan African Countries.
Nelson S; Kim J; Wilson FA; Soliman AS; Ngoma T; Kahesa C; Mwaiselage J
Value Health Reg Issues; 2016 Sep; 10():1-6. PubMed ID: 27881270
[TBL] [Abstract][Full Text] [Related]
10. An Insight Into Cervical Cancer Screening and Treatment Capacity in Sub Saharan Africa.
Coleman JS; Cespedes MS; Cu-Uvin S; Kosgei RJ; Maloba M; Anderson J; Wilkin T; Jaquet A; Bohlius J; Anastos K; Wools-Kaloustian K
J Low Genit Tract Dis; 2016 Jan; 20(1):31-7. PubMed ID: 26579842
[TBL] [Abstract][Full Text] [Related]
11. The Single-Visit Approach as a Cervical Cancer Prevention Strategy Among Women With HIV in Ethiopia: Successes and Lessons Learned.
Shiferaw N; Salvador-Davila G; Kassahun K; Brooks MI; Weldegebreal T; Tilahun Y; Zerihun H; Nigatu T; Lulu K; Ahmed I; Blumenthal PD; Asnake M
Glob Health Sci Pract; 2016 Mar; 4(1):87-98. PubMed ID: 27016546
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and determinants of cervical cancer screening in five sub-Saharan African countries: A population-based study.
Ba DM; Ssentongo P; Musa J; Agbese E; Diakite B; Traore CB; Wang S; Maiga M
Cancer Epidemiol; 2021 Jun; 72():101930. PubMed ID: 33756434
[TBL] [Abstract][Full Text] [Related]
13. A systematic review of the effects of visual inspection with acetic acid, cryotherapy, and loop electrosurgical excision procedures for cervical dysplasia in HIV-infected women in low- and middle-income countries.
Forhan SE; Godfrey CC; Watts DH; Langley CL
J Acquir Immune Defic Syndr; 2015 Apr; 68 Suppl 3():S350-6. PubMed ID: 25768874
[TBL] [Abstract][Full Text] [Related]
14. Cost analysis of the National Breast and Cervical Cancer Early Detection Program: selected states, 2003 to 2004.
Ekwueme DU; Gardner JG; Subramanian S; Tangka FK; Bapat B; Richardson LC
Cancer; 2008 Feb; 112(3):626-35. PubMed ID: 18157831
[TBL] [Abstract][Full Text] [Related]
15. Estimation of the costs of cervical cancer screening, diagnosis and treatment in rural Shanxi Province, China: a micro-costing study.
Shi JF; Chen JF; Canfell K; Feng XX; Ma JF; Zhang YZ; Zhao FH; Li R; Ma L; Li ZF; Lew JB; Ning Y; Qiao YL
BMC Health Serv Res; 2012 May; 12():123. PubMed ID: 22624619
[TBL] [Abstract][Full Text] [Related]
16. Implementation of cervical cancer screening using visual inspection with acetic acid in rural Mozambique: successes and challenges using HIV care and treatment programme investments in Zambézia Province.
Moon TD; Silva-Matos C; Cordoso A; Baptista AJ; Sidat M; Vermund SH
J Int AIDS Soc; 2012 Jun; 15(2):17406. PubMed ID: 22713260
[TBL] [Abstract][Full Text] [Related]
17. Expanding the Single-Visit Approach for Cervical Cancer Prevention: Successes and Lessons From Burkina Faso.
Ouedraogo Y; Furlane G; Fruhauf T; Badolo O; Bonkoungou M; Pleah T; Lankoande J; Bicaba I; Bazant ES
Glob Health Sci Pract; 2018 Jun; 6(2):288-298. PubMed ID: 29959272
[TBL] [Abstract][Full Text] [Related]
18. CRYOTHERAPY FOLLOWING VISUAL INSPECTION WITH ACETIC ACID AND LUGOL'S IODINE (VIA/VILI) IN KHWISERO, WESTERN KENYA: LESSON FROM THE FIELD AFFECTING POLICY AND PRACTICE.
Ngichabe SK; Muthaura PN; Murungi C; Muyoka J; Omenge E; Muchiri L
East Afr Med J; 2013 Oct; 90(10):316-23. PubMed ID: 26862641
[TBL] [Abstract][Full Text] [Related]
19. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
Hristova L; Hakama M
Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
[TBL] [Abstract][Full Text] [Related]
20. Cancer in sub-Saharan Africa in 2020: a review of current estimates of the national burden, data gaps, and future needs.
Bray F; Parkin DM;
Lancet Oncol; 2022 Jun; 23(6):719-728. PubMed ID: 35550275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
